ArticleOTO open
The Impact of Bioabsorbable Nasal Implants, Nasal Radiofrequency Remodeling, and Anesthesia Type on Patient Selection for Nasal Valve Surgery.
Article in OTO open. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Objective: To compare patient demographics, comorbidities, anesthesia type, and trends in nasal valve implantation (NVI) and nasal radiofrequency remodeling (NRR) techniques versus traditional nasal valve repair (NVR). Study Design: Retrospective case-control. Setting: In total, 58 health care organizations (HCOs) across the United States. Methods: The TriNetX Research Network was queried from 2021 through 2023, forming three cohorts of patients who underwent (1) NVR, (2) NVI, or (3) NRR. Demographics, comorbidities, and anesthesia type were compared across groups at the time of intervention. Results: A total of 10,568 NVR, 764 NVI, and 485 NRR cases were identified. Patients undergoing NVI or NRR compared to NVR were more likely to be older and exhibit a higher prevalence of medical comorbidities, including sleep apnea, hyperlipidemia, type 2 diabetes, gastroesophageal reflux disease, liver disease, hypertension, ischemic heart disease, other heart diseases, cerebrovascular disease, hearing loss, and kidney disease (all Conclusion: NVI and NRR have provided surgeons with alternative treatment options for nasal valve collapse, especially for patients who are older and with a higher burden of medical comorbidities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.